Clinical Trial Update: S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 SWOG S1314 COXEN program completed to predict chemotherapy response in bladder cancer; results were posted in January 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-01-03